LTI-291
Important Notice: For research use only. We do not sell to patients.
Not your Region? View all Distributors
Important Notice: For research use only. We do not sell to patients.
Not your Region? View all Distributors
Discription | LTI-291 is a glucocerebrosidase (Gcase) activator for treatment of Parkinson's disease (PD). |
---|
Catalog Num | A17030 |
---|---|
Formula | C20H30N4O2 |
Molecular Weight | 358.48 |
CAS Number | 1919820-28-2 |
SMILES | O=C(C1=C2N=C(C)C=C(C)N2N=C1)N[C@H]3CC[C@H](OCCCCC)CC3 |
Synonyms | LTI 291, LTI291 |
Storage | Store lyophilized at -20ºC, keep desiccated. |
In vitro | DMSO | 31 mg/mL (86.47 mM) | |
Water | Insoluble | ||
Ethanol | 62 mg/mL (172.95 mM) | ||
* <1 mg/ml means slightly soluble or insoluble. * Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
0.1 mM | 27.9 mL | 139.48 mL | 278.96 mL |
0.5 mM | 5.58 mL | 27.9 mL | 55.79 mL |
1 mM | 2.79 mL | 13.95 mL | 27.9 mL |
5 mM | 0.56 mL | 2.79 mL | 5.58 mL |
Calculate the dilution required to prepare a stock solution. This equation is commonly abbreviated as: C1V1 = C2V2